Literature DB >> 8630281

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.

Y F Shi1, X Xie, C L Zhao, D F Ye, S M Lu, J J Hor, C C Pao.   

Abstract

The objectives of this study were to better our understanding of the carcinogenesis of gestational trophoblastic tumours and to investigate the possible presence of mutational alteration of the p53 tumour-suppressor gene in these tumours. Amplification-based direct DNA sequencing was performed on 14 hydatidiform moles, six invasive moles, eight choriocarcinomas and ten normal early placental tissues. No mutation in exons 5-8 was detected in any of these 38 tissue specimens. These results suggest that a mutation in p53 tumour suppressor either does not exist or is a very rare event in gestational trophoblastic tumours. The gestational trophoblastic tumours probably involve a tumour-suppressor gene other than p53 gene or may follow a completely different pathway to their malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630281      PMCID: PMC2074525          DOI: 10.1038/bjc.1996.233

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

Review 1.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

2.  Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta.

Authors:  A N Cheung; G Srivastava; S Pittaluga; T K Man; H Ngan; R J Collins
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

Review 3.  The p53 tumor suppressor gene frequently is altered in gynecologic cancers.

Authors:  A Berchuck; M F Kohler; J R Marks; R Wiseman; J Boyd; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1994-01       Impact factor: 8.661

4.  Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma.

Authors:  J S Castresana; M P Rubio; J J Vázquez; M Idoate; A J Sober; B R Seizinger; R L Barnhill
Journal:  Int J Cancer       Date:  1993-10-21       Impact factor: 7.396

5.  Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis.

Authors:  Y S Chang; Y J Lin; C N Tsai; C H Shu; M S Tsai; K B Choo; S T Liu
Journal:  Cancer Lett       Date:  1992-12-24       Impact factor: 8.679

6.  [Identification of a chromosome carrying a putative tumor suppressor gene in human choriocarcinoma by microcell-mediated chromosome transfer].

Authors:  S Miyamoto; M Sasaki; M Nishida; N Wake
Journal:  Hum Cell       Date:  1991-03       Impact factor: 4.174

7.  Inhibition of in vitro enzymatic DNA amplification reaction by ultra-violet light irradiation.

Authors:  C C Pao; J J Hor; P L Tsai; M Y Horng
Journal:  Mol Cell Probes       Date:  1993-06       Impact factor: 2.365

8.  p53 antigen in cervical condylomata, intraepithelial neoplasia, and carcinoma: relationship to HPV infection and integration.

Authors:  K Cooper; C S Herrington; M F Evans; K C Gatter; J O McGee
Journal:  J Pathol       Date:  1993-09       Impact factor: 7.996

9.  p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix.

Authors:  S Bosari; M Roncalli; G Viale; P Bossi; G Coggi
Journal:  J Pathol       Date:  1993-04       Impact factor: 7.996

Review 10.  The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Authors:  A J Levine; M E Perry; A Chang; A Silver; D Dittmer; M Wu; D Welsh
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  5 in total

Review 1.  Placental apoptosis in health and disease.

Authors:  Andrew N Sharp; Alexander E P Heazell; Ian P Crocker; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2010-09       Impact factor: 3.886

2.  Gestational choriocarcinoma associated with a germline TP53 mutation.

Authors:  Anne-Claire Brehin; Sophie Patrier-Sallebert; Gaëlle Bougeard; Gwendoline Side-Pfennig; Francisco Llamas Gutierrez; Aude Lamy; Elodie Colasse; Christine Kandel-Aznar; Capucine Delnatte; Eric Vuillemin; Sophie Sadot-Lebouvier; Sylvie Odent; Jean-Christophe Sabourin; François Golfier; Thierry Frebourg
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

3.  Immunohistochemistry Study of P53 and C-erbB-2 Expression in Trophoblastic Tissue and Their Predictive Values in Diagnosing Malignant Progression of Simple Molar Pregnancy.

Authors:  Malihe Hasanzadeh; Norrie Sharifi; Marjaneh Farazestanian; Seyed Saman Nazemian; Faezeh Madani Sani
Journal:  Iran J Cancer Prev       Date:  2016-06-13

4.  MicroRNA-34a is a tumor suppressor in choriocarcinoma via regulation of Delta-like1.

Authors:  Ronald Tk Pang; Carmen On Leung; Cheuk-Lun Lee; Kevin Kw Lam; Tian-Min Ye; Philip Cn Chiu; William Sb Yeung
Journal:  BMC Cancer       Date:  2013-01-18       Impact factor: 4.430

Review 5.  Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner.

Authors:  Jennifer A Cotter; Linda Szymanski; Catherine Karimov; Lara Boghossian; Ashley Margol; Girish Dhall; Benita Tamrazi; G Isaac Varaprasathan; David M Parham; Alexander R Judkins; Jaclyn A Biegel
Journal:  Cold Spring Harb Mol Case Stud       Date:  2018-04-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.